Fundraise

China's INFevo raises $15M early round for virtual cell AI

What's the deal? Chinese virtual cell startup INFevo has raised US$13.8M in an early-stage round, the company said. New backers Xinglian Capital, Prosperity7Dealroom has a profile for this one. Try Dealroom →, Huagai CapitalDealroom has a profile for this one. Try Dealroom →, Huakong FundDealroom has a profile for this one. Try Dealroom →, and Deyuan Capital led the round, while existing investors Shunwei Capital, Sequoia China, and Sunny Fund added money.

What's the endgame? INFevo, incubated by Hong Kong-listed XtalPi, builds AI "virtual cell" models that predict how cells respond to drugs or gene edits before lab experiments run. Its flagship OCOO-T model simulates gene expression changes and tops three single-cell perturbation benchmarks, the company said.

Why now? It is INFevo's second raise in six months, after a tens-of-millions-of-yuan seed round in June from Shunwei, Sequoia China, and Songhe Capital. The new money will fund base-model development, high-throughput automated lab systems, and ecosystem building.

What could go wrong? Reliable predictions need vast, high-quality cell-perturbation data — an industry bottleneck. One research estimate cited by the company puts available labelled data at roughly 1,000 times short of training needs, with failed experiments rarely published.

To test predictions against reality, INFevo joined a Beijing key laboratory led by Peking University First Hospital focused on patient-derived organoids. "This may be slower than topping public datasets, but it's the path virtual cells must take into frontline drug discovery," the company said.

The signal: China's virtual cell sector is heating fast: industry tracker Vbdata counted nearly 10 rounds since April 2026, drawing Sequoia, Legend Capital, and Baidu VenturesDealroom has a profile for this one. Try Dealroom →. Global funding in the field has topped $3 billion. But round sizes alone don't prove the models yet work as a reliable engine for drug discovery.

Read more: 36kr.com

Image credit: Generated with Gemini

More top stories